Why Lucira Health Shares Are Trading Higher By Over 228%; Here Are 20 Stocks Moving Premarket

Gainers

• Lucira Health, Inc. (NASDAQ:LHDX) rose 228.5% to $0.46 in pre-market trading after the FDA authorized Lucira's over-the-counter at-home test to detect both influenza and COVID-19 viruses.
• ObsEva SA (NASDAQ:OBSV) rose 60.3% to $0.1331 in pre-market trading. ObsEva shares dropped over 50% on Friday after the company announced strategic reorganization to consolidate operations in Switzerland.
• Monopar Therapeutics Inc. (NASDAQ:MNPR) rose 19.8% to $3.92 in pre-market trading.
• Troika Media Group, Inc. (NASDAQ:TRKA) rose 16.4% to $0.3550 in pre-market trading after gaining over 17% on Friday.
• Inpixon (NASDAQ:INPX) rose 13% to $1.30 in pre-market trading.
• Seagen Inc. (NASDAQ:SGEN) rose 12.8% to $182.00 in pre-market trading. Pfizer is in early discussions to purchase Seagen in a deal likely valued at more than $30 billion, The Wall Street Journal reported late on Sunday.
• Kiromic BioPharma, Inc. (NASDAQ:KRBP) shares rose 12.4% to $0.1910 in pre-market trading after gaining over 5% on Friday.
• AERWINS Technologies Inc. (NASDAQ:AWIN) shares rose 10.7% to $1.86 in pre-market trading after gaining more than 10% on Friday.
• Molekule Group, Inc. (NASDAQ:MKUL) rose 9% to $2.67 in pre-market trading after the company agreed to acquire Aura Smart Air Ltd, in an all-stock merger with a value of around $10 million.
• Bed Bath & Beyond Inc. (NASDAQ:BBBY) shares rose 7.8% to $1.65 in pre-market trading.

Losers

• TEGNA Inc. (NYSE:TGNA) shares fell 24% to $16.61 in pre-market trading after the Federal Communications Commission announced plans to hold a hearing on Standard General's bid for Tegna.
• Cyren Ltd. (NASDAQ:CYRN) fell 19.1% to $0.2750 in pre-market trading after surging around 62% on Friday. CYREN, last week, said it will be delisted from the Nasdaq.
• Connexa Sports Technologies Inc. (NASDAQ:CNXA) fell 14% to $0.18 in pre-market after jumping more than 49% on Friday.
• Ocean Biomedical, Inc. (NASDAQ:OCEA) shares dropped 13.9% to $8.60 in pre-market trading after dropping over 7% on Friday. Ocean Biomedical recently issued a press release celebrating the discovery of bispecific antibodies and immune checkpoint inibitors that kill glioblastoma cells and melanoma cells and block the metastasis of malignant melanoma cells to the lung by over 90%.
• Jounce Therapeutics, Inc. (NASDAQ:JNCE) fell 7% to $1.07 in pre-market trading after gaining around 5% on Friday. Jounce Therapeutics and Redx recently announced a recommended business combination.
• Taboola.com Ltd. (NASDAQ:TBLA) fell 7% to $3.07 in pre-market trading. Taboola.com shares dropped 19% on Friday after the company reported Q4 financial results.
• SeqLL Inc. (NASDAQ:SQL) fell 6.5% to $0.71 in pre-market trading. SeqLL recently announced pricing of an $1.8 million registered direct offering.
• Zenvia Inc. (NASDAQ:ZENV) fell 6% to $1.10 in pre-market trading. Zenvia recently launched the integration of its mass texting service solution, Zenvia Attraction, with ChatGPT (GPT-3) via API.
• Protalix BioTherapeutics, Inc. (NYSE:PLX) shares fell 5% to $1.73 in pre-market trading after gaining 7% on Friday. Chiesi Global Rare Diseases and Protalix BioTherapeutics recently received CHMP opinion for pegunigalsidase alfa for treatment of Fabry disease.
• Kosmos Energy Ltd. (NYSE:KOS) fell 5% to $7.18 in pre-market trading after posting results for its fourth quarter. The company said it sees Q1 capex of $200 million to $225 million.

Now Read This: Investor Optimism Declines Following Inflation Report